ÂÜÀòÂÒÂ×

Dr. Shilpi Dhawan is an experienced clinical strategy leader with a robust background in pharmacology and medical research. Currently serving as Vice President of Clinical at Alvogen since December 2020, Dr. Dhawan is responsible for developing clinical strategies for complex generics and 505(b)(2) products, while enhancing execution of clinical operations. Prior roles include Head of Clinical Research at SUN PHARMA, where strategic input for new product development and regulatory strategy was provided, and Director of Global Trials at Dr. Reddy's Laboratories, overseeing bioequivalence studies across various therapeutic areas. Dr. Dhawan's educational credentials include a Doctor of Medicine in Pharmacology from Baba Raghav Das Medical College and an MBBS from SN Medical College.